Radcliffe Capital Management’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-327,150
| Closed | -$3.3M | – | 833 |
|
|
2022
Q4 | $3.3M | Hold |
327,150
| – | – | 0.1% | 307 |
|
|
2022
Q3 | $3.24M | Buy |
327,150
+27,150
| +9% | +$269K | 0.08% | 431 |
|
|
2022
Q2 | $2.94M | Hold |
300,000
| – | – | 0.07% | 499 |
|
|
2022
Q1 | $2.94M | Hold |
300,000
| – | – | 0.07% | 475 |
|
|
2021
Q4 | $2.91M | Hold |
300,000
| – | – | 0.08% | 418 |
|
|
2021
Q3 | $2.91M | Hold |
300,000
| – | – | 0.08% | 359 |
|
|
2021
Q2 | $2.9M | Buy |
+300,000
| New | +$2.9M | 0.09% | 369 |
|